Summary of the 43rd Annual J.P. Morgan Healthcare Conference Industry Overview - The conference is focused on the healthcare industry, featuring a wide range of companies from pharmaceuticals, biotechnology, medical devices, and healthcare services. Key Points and Arguments 1. Conference Dates and Location: The conference is scheduled from January 13 to January 16, 2025, at The Westin St. Francis in San Francisco, California [1][10][14]. 2. Keynote Speakers: Notable keynote speakers include Jamie Dimon, Chairman and CEO of JPMorgan Chase, and General (Ret.) Mark A. Milley, former Chairman of the Joint Chiefs of Staff [1][10][14]. 3. Diverse Participation: The agenda includes presentations from a variety of companies such as Bristol Myers Squibb, Roche Group, Johnson & Johnson, Pfizer, and many others, indicating a broad representation of the healthcare sector [1][10][14]. 4. Thought Leadership Panels: The conference features thought leadership panels that focus on various topics, including women's health and digital health, highlighting current trends and innovations in the industry [3][8][12]. 5. Networking Opportunities: Attendees have opportunities for networking through sessions and Q&A segments, which are integral for fostering connections within the healthcare community [2][7][11]. Important but Overlooked Content 1. Lunch Arrangements: Lunch is served in the Grand Ballroom with limited capacity, and overflow options are available, which may affect attendee experience and networking opportunities [2][11]. 2. Digital Conference Features: Video feeds of keynote sessions will be broadcasted in multiple rooms, ensuring wider access to presentations for attendees [2][11]. 3. Private Company Sessions: There are specific sessions dedicated to private companies, which may provide insights into emerging players in the healthcare market [1][10][14]. This summary encapsulates the essential details and insights from the conference agenda, emphasizing the significance of the event in the healthcare industry.
JPM 2025 Conference Agenda
Counterpoint Research·2025-01-15 07:05